Kaiser Foundation Health Plan Inc v. Merck & Company Inc. et al

JOINT STIPULATION AND ORDER REGARDING DISCOVERY SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Daniel A. Sasse (State Bar No. 236234)
Tiffanie L. McDowell (State Bar No. 288946)
CROWELL & MORING LLP
3 Park Plaza, 20th Floor
Irvine, California 92614
Telephone: 949.263.8400
Facsimile: 949.263.8414
dsasse@crowell.com
tmcdowell@crowell.com
Kent A. Gardiner (pro hac vice forthcoming)
Mark M. Supko (pro hac vice)
CROWELL & MORING LLP
1001 Pennsylvania Avenue NW
Washington, D.C. 20004
Telephone: 202.624.2500
Facsimile: 202.628.5116
kgardiner@crowell.com
msupko@crowell.com
Attorneys for Plaintiff
Kaiser Foundation Health Plan, Inc.
Samuel G. Liversidge
Shaun A. Mathur
Sarah M. Kushner
Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197
(213) 229-7000
sliversidge@gibsondunn.com
smkushner@gibsondunn.com
S. Christopher Whittaker
Courtney L. Spears
3161 Michelson Drive
Irvine, California 92612-4412
(949) 451-3800
cwhittaker@gibsondunn.com
cspears@gibsondunn.com
Attorneys for Defendants Merck & Co., Inc.,
Merck Sharp & Dohme LLC (f/k/a Merck
Sharp & Dohme Corp.), Schering-Plough
Corp., and Schering Corp., and MSP
Singapore Company LLC
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA, OAKLAND DIVISION
KAISER FOUNDATION HEALTH PLAN,
INC.,
Plaintiff,
v.
MERCK & COMPANY, INC.; MERCK
SHARP & DOHME CORPORATION;
SCHERING-PLOUGH CORPORATION;
SCHERING CORPORATION; MSP
SINGAPORE COMPANY LLC;
GLENMARK PHARMACEUTICALS LTD.;
AND GLENMARK PHARMACEUTICALS
INC., USA, Defendants.
Case No. 4:21-cv-05497-HSG
[Removed from San Francisco County
Superior Court Case No. CGC-21-592508]
JOINT STIPULATION AND
ORDER REGARDING DISCOVERY
SCHEDULE (as modified)
Jury Trial Demanded
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 1 of 9

1
JOINT STIPULATION AND ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Pursuant to Civil Local Rules 6-2 and 7-12, Merck & Company, Inc., Merck Sharp &
Dohme LLC (f/k/a Merck Sharp & Dohme Corporation), MSP Singapore Co. LLC, Schering-
Plough Corporation, and Schering Corporation (“Merck”), along with Plaintiff Kaiser Foundation
Health Plan Inc. (“Kaiser”), by and through their undersigned counsel of record, hereby stipulate
as follows:
WHEREAS, on May 1, 2025, the Court entered an Order setting a case schedule (ECF No.
76);
WHEREAS, on August 7, 2025, the Court entered an Order granting the Parties’ stipulation
to revise the case schedule to align the deadlines in this case with those in two related opt-out
actions pending in the United States District Court for the District of New Jersey1 (ECF No. 97);
WHEREAS, on January 16, 2026, the Court entered an Order granting the Parties’
stipulation to revise the case schedule to extend certain discovery deadlines by four weeks (ECF
No. 112);
WHEREAS, the court in the Humana and Centene actions ordered the parties to submit a
revised case schedule for those actions that would extend the time for fact and expert witness
discovery and the parties submitted a proposed schedule to the Court on February 10, 2026;
WHEREAS, the Parties have met and conferred and agreed that it will promote efficiency
and conserve attorney, Party, and judicial resources to keep the schedule in this action aligned with
the case schedules in the Humana and Centene actions;
WHEREAS, the Parties have agreed on a proposed schedule that will not require changing
the current deadlines for close of expert discovery, the filing of dispositive and Daubert motions,
the hearing date for disposition and Daubert motions, the pretrial conference, or the trial date; and
THEREFORE, THE PARTIES HEREBY AGREE AND STIPULATE, PURSUANT
TO CIVIL L.R. 6-2(a), AS FOLLOWS:
The dates and deadlines in this action shall be as follows:
1 The other “opt-out” actions with overlapping counsel for the parties are Humana Inc. v. Merck
& Co., Inc. et al., No. 2:23-cv-23023- BRM-LDW (D.N.J.) (“Humana”), Centene Corp. et al. v.
Merck & Co., Inc. et al., No. 2:23-cv23033-BRM-LDW (D.N.J.) (“Centene”).
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 2 of 9

2
JOINT STIPULATION AND ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Event 	Current Date 	Proposed Revised Date
Substantial Completion
Deadline January 30, 2026 	Same
Close of Fact Discovery 	March 12, 2026 	May 1, 2026
Deadline to file Non-
dispositive Motions March 12, 2026 	May 1, 2026
Opening Expert Reports 	May 1, 2026 	May 29, 2026
Rebuttal Expert Reports 	July 10, 2026 	July 17, 2026
Close of Expert Discovery 	September 15, 2026 	September 15, 2026
Deadline to file Dispositive
and Daubert Motions October 13, 2026 	Same
Deadline to file Oppositions
to Dispositive and Daubert
Motions
November 24, 2026 	Same
Deadline to file Replies to
Dispositive and Daubert
Motions
December 29, 2026 	Same
Dispositive and Daubert
Motions Hearing February 11, 2027 at 2:00 p.m. 	Same
Pretrial Conference 	May 11, 2027 at 3:00 p.m. 	Same
Jury Trial 	June 1, 2027 (15 days) 	Same
IT IS SO STIPULATED.
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 3 of 9

3
JOINT STIPULATION AND [PROPOSED] ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Dated: February 13, 2026 	Respectfully submitted,
CROWELL & MORING LLP
/s/ Tiffanie L. McDowell
Daniel A. Sasse (State Bar No. 236234)
Tiffanie L. McDowell (State Bar No. 288946)
CROWELL & MORING LLP
3 Park Plaza, 20th Floor
Irvine, California 92614
Telephone: 949.263.8400
Facsimile: 949.263.8414
dsasse@crowell.com
tmcdowell@crowell.com
Kent A. Gardiner (pro hac vice forthcoming)
Mark M. Supko (pro hac vice)
CROWELL & MORING LLP
1001 Pennsylvania Avenue NW
Washington, D.C. 20004
Telephone: 202.624.2500
Facsimile: 202.628.5116
kgardiner@crowell.com
msupko@crowell.com
Attorneys for Plaintiff Kaiser Foundation Health
Plan, Inc.
Dated: February 13, 2026 	/s/ Shaun A. Mathur
Samuel G. Liversidge, SBN 180578
Shaun A. Mathur, SBN 311029
Sarah M. Kushner, SBN 320077
GIBSON DUNN & CRUTCHER LLP
333 South Grand Avenue
Los Angeles, California 90071-3197
(213) 229-7000
sliversidge@gibsondunn.com
smkushner@gibsondunn.com
S. Christopher Whittaker, SBN 283518
Courtney L. Spears, SBN 329521
GIBSON DUNN & CRUTCHER LLP
3161 Michelson Drive
Irvine, California 92612-4412
(949) 451-3800
cwhittaker@gibsondunn.com
cspears@gibsondunn.com
Attorneys for Defendants Merck & Co., Inc.,
Merck Sharp & Dohme LLC (f/k/a Merck Sharp
& Dohme Corp.), Schering-Plough Corp., and
Schering Corp., and MSP Singapore Company
LLC
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 4 of 9

4
JOINT STIPULATION AND ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
ATTESTATION PER Civil L.R. 5-1(i)(3)
I attest that concurrence in the filing of the document has been obtained from each of the
other signatories indicated by a conformed signature (/s/) within this e-filed document.
Dated: February 13, 2026 	/s/ Tiffanie L. McDowell
Tiffanie L. McDowell
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 5 of 9

5
JOINT STIPULATION AND ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
CERTIFICATE OF SERVICE
I hereby certify that on February 13, 2026, I electronically filed the foregoing document
with the Clerk of the Court using the Court’s CM/ECF system, which will send a notice of
electronic filing to all CM/ECF participants.
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 6 of 9

6
JOINT STIPULATION AND ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
/s/ Tiffanie L. McDowell
Tiffanie L. McDowell
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 7 of 9

7
JOINT STIPULATION AND ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
ORDER
The Court, having reviewed the above Stipulation of Plaintiff and Defendants and good
cause appearing therefore, ORDERS as follows:
1. The Fact Discovery Deadline, which is currently March 12, 2026, shall now be
moved to May 1, 2026.
2. The Deadline to file any Non-Dispositive Motions related to fact discovery, which
is currently March 12, 2026, shall be moved to May 1, 2026.
3. The Deadline to exchange Opening Expert Reports, which is currently May 1, 2026,
shall be moved to May 29, 2026.
4. The Deadline to exchange Rebuttal Expert Reports, which is currently July 10, 2026,
shall be moved to on July 17, 2026.
5. 	All other deadlines shall remain unchanged.
Event 	Revised Date
Substantial Completion Deadline 	January 30, 2026
Close of Fact Discovery 	May 1, 2026
Deadline to file Non-dispositive Motions 	May 1, 2026
Opening Expert Reports 	May 29, 2026
Rebuttal Expert Reports 	July 17, 2026
Close of Expert Discovery 	September 15, 2026
Deadline to file Dispositive and Daubert
Motions October 13, 2026
Deadline to file Oppositions to Dispositive
and Daubert Motions November 24, 2026
Deadline to file Replies to Dispositive and
Daubert Motions December 29, 2026
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 8 of 9

8
JOINT STIPULATION AND ORDER RE CASE SCHEDULE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Dispositive and Daubert Motions Hearing 	February 11, 2027 at 2:00 p.m.
Pretrial Conference 	May 11, 2027 at 3:00 p.m.
Jury Trial 	June 1, 2027 (15 days)
PURSUANT TO STIPULATION, IT IS SO ORDERED.
Dated: 2/17/2026
Hon. Haywood S. Gilliam, Jr.
Case 4:21-cv-05497-HSG Document 118 Filed 02/17/26 Page 9 of 9